{"id":54200,"date":"2012-10-13T16:20:23","date_gmt":"2012-10-13T16:20:23","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/nasa-developing-motion-sickness-nasal-spray.php"},"modified":"2012-10-13T16:20:23","modified_gmt":"2012-10-13T16:20:23","slug":"nasa-developing-motion-sickness-nasal-spray","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nasa\/nasa-developing-motion-sickness-nasal-spray.php","title":{"rendered":"NASA developing motion sickness nasal spray"},"content":{"rendered":"<p><p>HOUSTON --  <\/p>\n<p>    Coming to a drug store near you -- a nasal spray that helps    fight motion sickness developed by NASA.  <\/p>\n<p>    NASA's Johnson Space Center in Houston and Epiomed Therapeutics    Inc. of Irvine, Calif., have signed an agreement to develop and    commercialize a NASA-crafted, fast-acting nasal spray to fight    motion sickness.<\/p>\n<p>    Under the Space Act Agreement, Epiomed will formulate the drug,    called intranasal scopolamine, or INSCOP.  <\/p>\n<p>    Astronauts often experience motion sickness in space. As a    result, NASA has conducted extensive research into the causes    and treatments for the condition. Scopolamine is effective and    can be administered as a tablet or injected. With a precise    dosage, the NASA spray formulation has been shown to work    faster and more reliably than the oral form.  <\/p>\n<p>    \"NASA and Epiomed will work closely together on further    development of NSCOP to optimize therapeutic efficiency for    both acute and chronic treatment of motion sickness which can    be used by NASA, the Department of Defense and world travelers    on land, in the air and on the seas,\" said Lakshmi Putcha,    developer of the innovative treatment strategy at Johnson.  <\/p>\n<p>    A gel formulation of INSCOP was developed and tested under a    Space Act Agreement between Johnson and the Naval Aerospace    Medical Research Laboratory in Pensacola. Results from that    trial were published in the journal Aviation, Space and    Environmental Medicine in April 2010 that suggest INSCOP is a    fast-acting and reliable way to prevent and treat motion    sickness.  <\/p>\n<p>    The U.S. Navy is working on an agreement with Epiomed to test    the nasal spray. NASA and Epiomed will collaborate on clinical    trials related to the Federal Drug Administration requirements.  <\/p>\n<p>    NASA is transferring sponsorship of future clinical trials and    FDA approvals to Epiomed, which will supply the product for use    by NASA and others.<\/p>\n<\/p>\n<p>Continued here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.cfnews13.com\/content\/news\/cfnews13\/news\/article.html\/content\/news\/articles\/cfn\/2012\/10\/12\/nasa_developing_moti\/?cid=rss\" title=\"NASA developing motion sickness nasal spray\">NASA developing motion sickness nasal spray<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> HOUSTON -- Coming to a drug store near you -- a nasal spray that helps fight motion sickness developed by NASA. NASA's Johnson Space Center in Houston and Epiomed Therapeutics Inc <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nasa\/nasa-developing-motion-sickness-nasal-spray.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[20],"tags":[],"class_list":["post-54200","post","type-post","status-publish","format-standard","hentry","category-nasa"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/54200"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=54200"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/54200\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=54200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=54200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=54200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}